Privia Health Group, Inc.
PRVA
Positions held
Your positionsPRVA isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Privia Health Group is well-positioned in the growing health information services industry, which is expected to expand as healthcare providers increasingly adopt technology solutions.
- Revenue increased by 5% compared to the prior quarter, reaching $633 million.
- The company has shown consistent revenue growth, with a year-over-year increase of 21.4%.
- Despite growth, Privia Health has a high trailing P/E ratio of 96.57, indicating potential overvaluation.
- The company's operating margin has been declining, with a recent figure of 1.86%, down from 2.48% in the previous quarter.
- The stock has a 'Sell' signal with a score of -13.00, indicating negative market sentiment.
Fundamentals
| Market cap | $2.58B | Enterprise value | $2.23B | Trailing P/E | 96.14 | Forward P/E | 18.99 |
| PEG | — | Price / book | 3.26 | Beta | 0.80 | Dividend yield | 0.00% |
| Revenue growth | 21.4% | Earnings growth | 250.0% | Gross margin | 10.0% | Operating margin | 1.9% |
| Profit margin | 1.2% | ROE | 4.3% | ROA | 2.0% | Debt / equity | 0.01 |
| Current ratio | 1.62 | Free cash flow | $95.65M | Analyst recommendation | strong_buy | Mean target | $31.47 |
| 52w high | $28.82 | 52w low | $18.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $633M | $604M | $541M | $580M | $521M | — |
| Op margin | 1.9% | 1.2% | 2.1% | 2.5% | 0.6% | — |
| Net income | $9.0M | $3.1M | $9.2M | $6.9M | $2.7M | — |
| Gross margin | 9.9% | 10.0% | 9.2% | 11.0% | 9.6% | — |
| Gross profit | $62.8M | $60.3M | $49.7M | $63.8M | $50.2M | — |
| Operating income | $11.8M | $7.4M | $11.3M | $14.4M | $3.3M | — |
- Revenue +5% vs prior quarter ($633M vs $604M).
- Gross margin 9.9% (was 10% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.1B | $1.7B | $1.7B | $1.4B | — |
| Op margin | 1.6% | 1.0% | 1.2% | -1.4% | — |
| Net income | $22.9M | $14.4M | $23.1M | -$8.6M | — |
| Gross margin | 9.9% | 10.2% | 9.7% | 9.9% | — |
| Gross profit | $209M | $177M | $162M | $135M | — |
| Operating income | $34.2M | $17.0M | $20.6M | -$19.1M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
2026-10-05 · 3 Stocks Under $50 We Keep Off Our Radar
2026-09-30 · 2 Growth Stocks to Stash and 1 We Turn Down
2026-09-19 · Why Privia Health Group (PRVA) Is Getting Attention Now
2026-09-19 · Privia Health Group (PRVA) Stock Looks Rich Against Current Earnings
2026-09-18 · Dell and 4 More Stocks See Action From Activist Investors
2026-09-16 · 1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
2026-09-14 · 3 Out-of-Favor Stocks We’re Skeptical Of
2026-09-10 · Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest
2026-09-03 · 1 Cash-Producing Stock for Long-Term Investors and 2 Facing Challenges
2026-08-28 · 1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
2026-08-20 · Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings?
Price (daily)
Full chart · RSI · MACD · patterns